Malaria burden and case management in the Republic of Congo: limited use and application of rapid diagnostic tests results

[1] Conway DJ(2000)A principal target of human immunity to malaria identified by molecular population genetic and immunological analyses Nature Med 6 689-92

[2] Cavanagh DR(2008)Extensive dynamics of Plasmodium falciparum densities, stages and genotyping profiles Malaria J 7 241-71

[3] Tanabe K(2007)Efficacy of sulfadoxine-pyrimethamine, amodiaquine, and sulfadoxine-pyrimethamine-amodiaquine combination for the treatment of uncomplicated falciparum malaria in the urban and suburban areas of Brazzaville (Congo) Acta Tropica 103 163-18

[4] Färnert A(2011)Genetic polymorphism of merozoite surface protein-1 and merozoite surface protein-2 in Plasmodium falciparum isolates from Brazzaville, Republic of Congo Malaria J 10 276-203

[5] Lebbad M(2012)Genetic polymorphism of merozoite surface protein 2 and prevalence of K76T pfcrt mutation in Plasmodium falciparum field isolates from Congolese children with asymptomaticinfections Malaria J 11 105-547

[6] Faraja L(1987)Malaria and urbanization in Central Africa: the example of Brazzaville. Part II: Results of entomological surveys and epidemiological analysis Trans Roy Soc Trop Med and Hyg 81 10-1373

[7] Ndounga M(2000)Site-based study on polymorphism of P. falciparum MSP-1 and MSP-2 genes in isolates from two villages in Central Africa Parassitologia 42 197-256

[8] Mayengue PI(2003)Comparison of two conventional techniques used for the diagnosis of tuberculosis cases Int J Ag and Biol 5 545-9

[9] Tahar R(2004)Tips for learners of evidence –based medicine: 3. Measures of observer variability (Kappa statistic) Canadian Med As J 171 1369-1171

[10] Mayengue PI(2011)Implementing ideal health policy in a fragile health system: the example of expanding the use of malaria rapid diagnostic tests in mainland Tanzania Malaria J 28 10,322-225

[1] Conway DJ(2000)A principal target of human immunity to malaria identified by molecular population genetic and immunological analyses Nature Med 6 689-92

[2] Cavanagh DR(2008)Extensive dynamics of Plasmodium falciparum densities, stages and genotyping profiles Malaria J 7 241-71

[3] Tanabe K(2007)Efficacy of sulfadoxine-pyrimethamine, amodiaquine, and sulfadoxine-pyrimethamine-amodiaquine combination for the treatment of uncomplicated falciparum malaria in the urban and suburban areas of Brazzaville (Congo) Acta Tropica 103 163-18

[4] Färnert A(2011)Genetic polymorphism of merozoite surface protein-1 and merozoite surface protein-2 in Plasmodium falciparum isolates from Brazzaville, Republic of Congo Malaria J 10 276-203

[5] Lebbad M(2012)Genetic polymorphism of merozoite surface protein 2 and prevalence of K76T pfcrt mutation in Plasmodium falciparum field isolates from Congolese children with asymptomaticinfections Malaria J 11 105-547

[6] Faraja L(1987)Malaria and urbanization in Central Africa: the example of Brazzaville. Part II: Results of entomological surveys and epidemiological analysis Trans Roy Soc Trop Med and Hyg 81 10-1373

[7] Ndounga M(2000)Site-based study on polymorphism of P. falciparum MSP-1 and MSP-2 genes in isolates from two villages in Central Africa Parassitologia 42 197-256

[8] Mayengue PI(2003)Comparison of two conventional techniques used for the diagnosis of tuberculosis cases Int J Ag and Biol 5 545-9

[9] Tahar R(2004)Tips for learners of evidence –based medicine: 3. Measures of observer variability (Kappa statistic) Canadian Med As J 171 1369-1171

[10] Mayengue PI(2011)Implementing ideal health policy in a fragile health system: the example of expanding the use of malaria rapid diagnostic tests in mainland Tanzania Malaria J 28 10,322-225